Kirsten rat sarcoma virus (KRAS) mutations are prevalent genetic alterations in cancer and are found in 20%–25% and 10%–15% of adenocarcinoma cases in Western populations and Asia, respectively.1 This evidence concerns the gene KRAS and cancer.